Publications by authors named "Louis Garry"

Claim this Profile
T
The CTX-M-15-producing Escherichia coli clone O25b: H4-ST131 has high intestine colonization and urinary tract infection abilities.
Sophie Vimont, Anders Boyd, Alexandre Bleibtreu, Marcelle Bens, Jean-Michel Goujon, Louis Garry

PLoS One· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The interaction between a non-pathogenic and a pathogenic strain synergistically enhances extra-intestinal virulence in Escherichia coli.
Jérôme Tourret, Meryem Aloulou, Louis Garry, Olivier Tenaillon, Sara Dion

Microbiology (Reading)· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The in vitro contribution of autolysins to bacterial killing elicited by amoxicillin increases with inoculum size in Enterococcus faecalis.
Vincent Dubée, Françoise Chau, Michel Arthur, Louis Garry, Samira Benadda

Antimicrob Agents Chemother· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of single and multiple pathogenicity island deletions on uropathogenic Escherichia coli strain 536 intrinsic extra-intestinal virulence.
Jérôme Tourret, Médéric Diard, Louis Garry, Ivan Matic, Erick Denamur

Int J Med Microbiol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathogenicity-associated islands in extraintestinal pathogenic Escherichia coli are fitness elements involved in intestinal colonization.
Médéric Diard, Louis Garry, Marjorie Selva, Thomas Mosser, Erick Denamur

J Bacteriol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Probable intrafamily transmission of a highly virulent CTX-M-3-producing Escherichia coli belonging to the emerging phylogenetic subgroup D2 O102-ST405 clone.
Liliana Mihaila, Benjamin Wyplosz, Olivier Clermont, Louis Garry, Marie Claire Hipeaux

J Antimicrob Chemother· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
aes, the gene encoding the esterase B in Escherichia coli, is a powerful phylogenetic marker of the species.
Mathilde Lescat, Claire Hoede, Olivier Clermont, Louis Garry, Pierre Darlu

BMC Microbiol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of the autolysin AtlA to the bactericidal activity of amoxicillin against Enterococcus faecalis JH2-2.
Anne-Lise Bravetti, Stéphane Mesnage, Agnès Lefort, Françoise Chau, Catherine Eckert, Louis Garry

Antimicrob Agents Chemother· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Organised genome dynamics in the Escherichia coli species results in highly diverse adaptive paths.
Marie Touchon, Claire Hoede, Olivier Tenaillon, Valérie Barbe, Simon Baeriswyl, Louis Garry

PLoS Genet· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of hypermutability on bacterial fitness and emergence of resistance in experimental osteomyelitis due to Staphylococcus aureus.
Claire Daurel, Anne-Laure Prunier, Françoise Chau, Louis Garry, Roland Leclercq

FEMS Immunol Med Microbiol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between the level of acquired resistance to gentamicin and synergism with amoxicillin in Enterococcus faecalis.
Elisabeth Aslangul, Raymond Ruimy, Françoise Chau, Louis Garry, Antoine Andremont

Antimicrob Agents Chemother· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutator phenotype confers advantage in Escherichia coli chronic urinary tract infection pathogenesis.
Francoise Labat, Olivier Pradillon, Louis Garry, Michel Peuchmaur, Bruno Fantin

FEMS Immunol Med Microbiol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activities of dalbavancin in vitro and in a rabbit model of experimental endocarditis due to Staphylococcus aureus with or without reduced susceptibility to vancomycin and teicoplanin.
Agnès Lefort, Juliette Pavie, Louis Garry, Françoise Chau, Bruno Fantin

Antimicrob Agents Chemother· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of VanD type resistance on activities of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faecium.
Agnès Lefort, Louis Garry, Florence Depardieu, Patrice Courvalin, Bruno Fantin

Antimicrob Agents Chemother· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of reduced susceptibility to glycopeptides on activities of vancomycin and teicoplanin against Staphylococcus aureus in experimental endocarditis.
Juliette Pavie, Agnès Lefort, Marie-Cécile Ploy, Laurent Massias, Françoise Chau, Louis Garry

Antimicrob Agents Chemother· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacies of quinupristin-dalfopristin combined with vancomycin in vitro and in experimental endocarditis due to methicillin-resistant Staphylococcus aureus in relation to cross-resistance to macrolides, lincosamides, and streptogramin B- type antibiotics.
Juliette Pavie, Agnès Lefort, Virginie Zarrouk, Françoise Chau, Louis Garry

Antimicrob Agents Chemother· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis